Header Logo

Connection

Sara Vesely to National Heart, Lung, and Blood Institute (U.S.)

Back to Details
This is a "connection" page, showing publications Sara Vesely has written about National Heart, Lung, and Blood Institute (U.S.).
Sara Vesely
Connection Strength
0.037
National Heart, Lung, and Blood Institute (U.S.)
  1. Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
    View in: PubMed
    Score: 0.037
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.